Barclays
AMED

Barclays’s Amedisys AMED Stock Holding History

Barclays’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,221
Closed -$1.4M – 5468
2025
Q2 		$1.4M Sell
14,221
-25,085
-64% -$2.37M ﹤0.01% 3109
2025
Q1 		$3.64M Sell
39,306
-28,004
-42% -$2.58M ﹤0.01% 2159
2024
Q4 		$6.11M Buy
67,310
+51,781
+333% +$4.76M ﹤0.01% 1975
2024
Q3 		$1.5M Buy
15,529
+5,142
+50% +$502K ﹤0.01% 3080
2024
Q2 		$954K Sell
10,387
-31,915
-75% -$2.96M ﹤0.01% 2626
2024
Q1 		$3.9M Sell
42,302
-68,329
-62% -$6.4M ﹤0.01% 2031
2023
Q4 		$10.5M Sell
110,631
-16,934
-13% -$1.58M ﹤0.01% 1483
2023
Q3 		$11.9M Buy
127,565
+77,074
+153% +$7.12M 0.01% 927
2023
Q2 		$4.62M Buy
50,491
+43,293
+601% +$3.55M ﹤0.01% 1396
2023
Q1 		$529K Sell
7,198
-6,401
-47% -$554K ﹤0.01% 3231
2022
Q4 		$1.14M Sell
13,599
-1,986
-13% -$179K ﹤0.01% 2697
2022
Q3 		$1.51M Buy
15,585
+1,319
+9% +$157K ﹤0.01% 1931
2022
Q2 		$1.5M Buy
14,266
+14,046
+6,385% +$1.79M ﹤0.01% 2047
2022
Q1 		$38K Sell
220
-8,278
-97% -$1.24M ﹤0.01% 4218
2021
Q4 		$1.38M Sell
8,498
-23,900
-74% -$3.84M ﹤0.01% 2615
2021
Q3 		$4.83M Sell
32,398
-7,713
-19% -$1.6M ﹤0.01% 1672
2021
Q2 		$9.82M Buy
40,111
+36,398
+980% +$9.55M ﹤0.01% 1203
2021
Q1 		$983K Sell
3,713
-6,510
-64% -$1.84M ﹤0.01% 2792
2020
Q4 		$3M Buy
10,223
+873
+9% +$224K ﹤0.01% 1925
2020
Q3 		$2.21M Sell
9,350
-7,133
-43% -$1.62M ﹤0.01% 2010
2020
Q2 		$3.27M Sell
16,483
-3,514
-18% -$655K ﹤0.01% 1700
2020
Q1 		$3.67M Sell
19,997
-17,483
-47% -$3.11M ﹤0.01% 1734
2019
Q4 		$6.25M Buy
37,480
+18,673
+99% +$2.78M ﹤0.01% 1798
2019
Q3 		$2.46M Sell
18,807
-8,849
-32% -$1.15M ﹤0.01% 2612
2019
Q2 		$3.36M Sell
27,656
-11,786
-30% -$1.4M ﹤0.01% 2297
2019
Q1 		$4.86M Sell
39,442
-3,487
-8% -$438K ﹤0.01% 1687
2018
Q4 		$5.03M Sell
42,929
-8,607
-17% -$1.01M ﹤0.01% 1600
2018
Q3 		$6.44M Buy
51,536
+27,015
+110% +$2.98M ﹤0.01% 1571
2018
Q2 		$2.1M Buy
24,521
+9,996
+69% +$734K ﹤0.01% 2545
2018
Q1 		$877K Buy
14,525
+3,756
+35% +$214K ﹤0.01% 3365
2017
Q4 		$567K Buy
10,769
+4,256
+65% +$224K ﹤0.01% 3676
2017
Q3 		$364K Sell
6,513
-16,285
-71% -$861K ﹤0.01% 3903
2017
Q2 		$1.43M Buy
22,798
+6,286
+38% +$366K ﹤0.01% 2557
2017
Q1 		$844K Buy
16,512
+12,235
+286% +$584K ﹤0.01% 2881
2016
Q4 		$182K Sell
4,277
-34,154
-89% -$1.45M ﹤0.01% 4291
2016
Q3 		$1.82M Sell
38,431
-238
-0.6% -$11.9K ﹤0.01% 2077
2016
Q2 		$1.95M Buy
38,669
+2,042
+6% +$103K ﹤0.01% 2020
2016
Q1 		$1.76M Sell
36,627
-11,462
-24% -$442K ﹤0.01% 2035
2015
Q4 		$1.88M Buy
48,089
+47,942
+32,614% +$1.92M ﹤0.01% 2069
2015
Q3 		$5K Sell
147
-2,392
-94% -$101K ﹤0.01% 6030
2015
Q2 		$99K Buy
2,539
+1,719
+210% +$53.6K ﹤0.01% 4677
2015
Q1 		$21K Sell
820
-20,401
-96% -$576K ﹤0.01% 5789
2014
Q4 		$616K Sell
21,221
-12,547
-37% -$310K ﹤0.01% 3659
2014
Q3 		$676K Sell
33,768
-14,595
-30% -$282K ﹤0.01% 3688
2014
Q2 		$775K Sell
48,363
-25,300
-34% -$359K ﹤0.01% 3567
2014
Q1 		$1.03M Sell
73,663
-30,327
-29% -$467K ﹤0.01% 3208
2013
Q4 		$1.46M Buy
103,990
+5,849
+6% +$94.2K ﹤0.01% 2991
2013
Q3 		$1.67M Buy
98,141
+754
+0.8% +$11.2K ﹤0.01% 2798
2013
Q2 		$1.13M Buy
+97,387
New +$1.12M ﹤0.01% 3208

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's AMED Position: Q3 2025 in Review

Barclays sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14,221 shares — an estimated $1.4M sold.

Barclays first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $11.9M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Barclays reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Barclays sold 14,221 Amedisys shares in Q3 2025, an estimated $1.4M.
  • Barclays first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Barclays's Amedisys position peaked at $11.9M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.